Your Immunotherapy Treatment Card — The Document to Carry Everywhere

Ten lines on one page. Name, age and blood group. The diagnosis. The exact immunotherapy drug and dose. First cycle date and most recent cycle date. Cycles completed. Your oncologist’s name and mobile. The centre’s 24-hour number. Current steroids and other medicines. Allergies. And one alert line naming the treatment.

Everything else on this page is for a calmer day. The card is deliberately dull: no folder, no app, no login, nothing that depends on a charged phone or a network signal at a district casualty at midnight. A piece of card in a pocket, written by hand if that is what you have, is more reliable than any of those. Write it in English, and add the same details in Telugu or the language spoken where you live, so that whoever is on duty can read it without having to ask the patient anything.

Because immune side effects look like ordinary illness. Loose motions look like food poisoning. Breathlessness looks like a chest infection. A doctor who does not know you are on immunotherapy treats the ordinary version. A doctor who does know thinks about colitis or pneumonitis, and calls your oncologist early.

• It names the drug. Checkpoint inhibitors are recognised by name in every emergency department that has seen one. Written on a card, that name reframes the whole consultation in about four seconds.
• It fixes the timeline. Whether the last dose was nine days or nine months ago changes what is likely and what is urgent. Under stress, dates are the first thing families lose.
• It gives the duty doctor someone to call. The decisions that matter here — holding the drug, starting steroids, admitting — belong with the treating oncologist. A number on the card is what makes that conversation happen tonight instead of tomorrow.
• It prevents the wrong first move. Immune colitis and pneumonitis are not managed the way an infection or an ordinary stomach upset is, and the difference matters within hours. The card tells the team there is a decision to be made rather than a routine to follow.
• It works when you are far from your own centre. On a train, in a district hospital, visiting family. Travel times are indicative and mostly irrelevant at that moment; what travels with you is the card.
• It carries the attendant through the questions. A spouse who has not slept is asked twelve questions at a registration desk. Handing over one card answers eleven of them, correctly, in the right words.

This is not a CION idea. Guidance from bodies including ASCO, ESMO and NCCN consistently advises that patients on immune checkpoint inhibitors carry documentation identifying the treatment, precisely because the presenting picture is so easy to read as something else. It is one of the smallest interventions in cancer care and one of the few that costs nothing at all.

From your treating centre first. Ask the oncologist or the day-care nurse for a written treatment summary and copy it onto a card. If no card exists, write it yourself from the prescription, the pharmacy bill and the discharge summary, then have the team check it at the next cycle. It costs nothing.

1. 1

   Ask your treating team for a written treatment summary

   You are entitled to it, and asking is routine rather than awkward. At CION it is part of ordinary day-care immunotherapy and may be requested at any cycle.

2. 2

   Copy it onto something that survives a pocket

   A laminated card, a plastic sleeve, or the back of an old visiting card in clear handwriting. It has to be readable after three months of being carried around.

3. 3

   Have it checked and signed at the next cycle

   Ask the nurse or oncologist to read it once and correct the drug name, dose and dates. A wrong dose on a card is worse than no card.

4. 4

   Photograph it on two phones

   The patient’s and the main attendant’s. Set it as a lock-screen image or save it in a favourites album so nobody has to search for it in a corridor.

5. 5

   Update it whenever something changes

   New cycle date, dose change, drug held, steroids started or stopped, new phone number. Two minutes at the end of each visit keeps it true.

6. 6

   Give a copy to whoever is at home

   The person who would ring for help if the patient could not. Distance and travel time are indicative; a copy in another house is not.

If your infusions happen in the city but your reviews and blood tests happen closer to home, the card matters more, not less, because two teams are relying on the same facts. That arrangement is worked through in Shared Care: Infusion in the City, Monitoring Near Home, and the district version of the journey in Immunotherapy Access From Districts of Telangana and Andhra Pradesh.

A thin folder for planned visits, kept packed. The pathology report. The biomarker report, such as PD-L1, if one was done. The latest blood reports. The last two day-care notes or discharge summaries. A current medicine list. The insurance or scheme papers, and the itemised estimate. The card is separate, and stays on the person.

• Pathology and biomarker reports. The originals of the biopsy report and any PD-L1, MSI or TMB testing. These are what a second opinion is built from, and reordering them takes days you may not want to spend.
• Recent bloods and day-care notes. The most recent full blood count, liver, kidney and thyroid results, and the notes from the last two cycles. Trends matter more than single values, so keep the older ones rather than discarding them.
• Imaging reports, and who holds them. Keep the reports and the CDs together. Response-assessment PET-CT is coordinated at partner imaging centres rather than done at CION, so those reports and those bills come to you from the imaging centre directly.
• Scheme and insurance papers. The policy or scheme card, the approval letters, and any dated written position you have been given. Get positions dated, because empanelment and package contents change.
• The itemised, dated cost estimate. Indicative, as of the date it carries. Keeping it in the folder makes it far easier to notice when a bill diverges from what was explained at the start.
• A single medicine list, updated by one person. Two half-updated lists in two handbags is a common and avoidable source of error. One list, one owner, rewritten whenever something changes.

Yes, and this is the part most families are never told. Immune-related side effects can start weeks after a cycle and sometimes months after the final dose. Thyroid and adrenal problems in particular surface late. Keep carrying the card for at least a year after treatment ends, with the last cycle date on it.

The reason is mechanical rather than mysterious. Checkpoint inhibitors work by releasing a brake on the immune system, and that release does not end neatly on the day the infusions stop. A patient who finished treatment in October and develops profound fatigue in February is, to any doctor who does not know the history, simply a tired person. The same patient with a card in their pocket is someone whose thyroid and adrenal function will be checked that afternoon.

So the rule is simple and it does not expire quickly: tell every doctor you see that you have had immunotherapy — the physician treating a fever, the surgeon planning an unrelated operation, the dentist, the doctor in a casualty at midnight. That habit is worth more than the card itself, and is set out in Always Tell Every Doctor You Are on Immunotherapy.

It cannot treat anything. It is a communication tool, not a prescription and not a reason to wait at home. It does not replace an escalation route, and it does not make a centre capable. It moves accurate information into a room quickly. Everything after that still depends on people.

• It is not permission to self-manage. Nothing on the card should be started, stopped or changed by the patient or the family. If new symptoms appear, the instruction is the same as it has always been: call the treating team now, or go to the nearest emergency department if it is severe.
• It does not substitute for a centre that can act. A card is only as useful as the escalation route behind it. If you are still choosing where to be treated, ask each centre who answers after hours and what happens in the first hour — the warning signs are set out in Red Flags When a Centre Recommends Immunotherapy.
• It does not compare hospitals. This page names no centre as better or worse than another. The card is meant to be carried by anyone on immunotherapy anywhere, and to be filled in with whichever team is treating you.
• It is not a CAR-T or cell-therapy record. CION does not provide CAR-T or cell therapy, and does not stock CAR-T products. If you have received or are considering one of those treatments, the documentation and the follow-up plan come from the accredited centre that delivered it; our role is orientation and onward referral only.
• It does not carry a price. Costs belong in the estimate in the folder, dated and itemised, and are indicative only. Nothing on a card should be used to compare what two centres charge.

For accuracy about our own service line: at CION, immunotherapy is administered as day care — you come in, are treated, and go home the same day. Response-assessment PET-CT is coordinated at partner imaging centres, not owned by CION. CION does not provide CAR-T or cell therapy. Ask any centre you approach to be equally specific about what it does itself and what it sends out.

The card assumes there is a team to call. If you are still deciding where to be treated, or treatment is being split between two places, these pages cover the questions that sit underneath the card — who answers at night, how the journey works from a district, and how shared care is kept safe.

• Red Flags When a Centre Recommends Immunotherapy — what should make you pause before agreeing, and what to ask when the offer arrives faster than the explanation.
• Immunotherapy Access From Districts of Telangana and Andhra Pradesh — planning cycles, unplanned return journeys and local fallback when home is hours away. Travel times indicative.
• Shared Care: Infusion in the City, Monitoring Near Home — how to split treatment and monitoring between two teams without losing the thread between them.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment, monitoring between cycles and cost counselling fit together as one pathway.

The Card Is Free. The Delay It Prevents Is Not.

Ask your treating team for a written treatment summary today, whoever is treating you. If that is us, ask at any cycle.